Rho GTPase-activating protein 35 rs1052667 polymorphism and osteosarcoma risk and prognosis. - Wikidata - awgldk - TriplyDB

Rho GTPase-activating protein 35 rs1052667 polymorphism and osteosarcoma risk and prognosis.

Rho GTPase-activating protein 35 rs1052667 polymorphism and osteosarcoma risk and prognosis.

http://www.wikidata.org/entity/Q34014581

about

NFKB1 -94ins/del ATTG polymorphism increases osteosarcoma risk in a Chinese Han population Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.Characterization of potential driver mutations involved in human breast cancer by computational approaches.Anticancer effects of 10-hydroxycamptothecin induce apoptosis of human osteosarcoma through activating caspase-3, p53 and cytochrome c pathways.P190RhoGAP prevents mitotic spindle fragmentation and is required to activate Aurora A kinase at acentriolar poles.Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis.

P2860

Q35173942-AA7E5994-395A-4FC0-AA9D-B70F4600CA10 Q36262912-9410CDF2-E5AD-4F09-BB9B-5B8CD22E7458 Q38850366-06376E5F-4D7B-44BC-930E-6389E9D97EAA Q39286993-66FACA5A-B0FE-4A42-92C7-32CEFE49E144 Q49422596-0DF04C43-5131-40DA-94E7-506F319D6D8E Q52719324-8F958A7C-516D-490A-90B4-F5B5F98E107E Q55004789-1D06901B-9347-43AD-970B-94F1F32F422E

P2860

Rho GTPase-activating protein 35 rs1052667 polymorphism and osteosarcoma risk and prognosis.

http://www.wikidata.org/entity/Q34014581

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Rho GTPase-activating protein ...... teosarcoma risk and prognosis.

@ast

Rho GTPase-activating protein ...... teosarcoma risk and prognosis.

@en

Rho GTPase-activating protein ...... teosarcoma risk and prognosis.

@nl

type

label

Rho GTPase-activating protein ...... teosarcoma risk and prognosis.

@ast

Rho GTPase-activating protein ...... teosarcoma risk and prognosis.

@en

Rho GTPase-activating protein ...... teosarcoma risk and prognosis.

@nl

prefLabel

Rho GTPase-activating protein ...... teosarcoma risk and prognosis.

@ast

Rho GTPase-activating protein ...... teosarcoma risk and prognosis.

@en

Rho GTPase-activating protein ...... teosarcoma risk and prognosis.

@nl

P1433

Q34014581-5B2F6BE1-5AC1-4CA3-BC02-CEF3FAAE0235

P1476

Q34014581-8D4B4454-14A4-41C1-8055-8ECDAE845A66

P2093

Q34014581-4C65F58E-9682-47EF-9A18-F4CFB8CE1395

Q34014581-522B5890-163A-4522-B707-F095D8E04192

Q34014581-E7729B6C-959D-4561-920D-38228ED0E512

P2860

Q34014581-04AEE239-E493-4776-90DC-4A9B8510CA82

Q34014581-25429EAA-6694-42EE-9D00-D9E36ACBF240

Q34014581-2917CCFA-7080-4452-843D-29124C365AD6

Q34014581-2BB99863-1EF3-4645-9512-6D326A5F4658

Q34014581-2E475BDE-43A2-4173-83CC-9FC06CF6F9CA

Q34014581-2F7CDFA5-9588-4E62-8A78-8020BB553494

Q34014581-30009C3E-2B31-4993-9296-D44F4D58D756

Q34014581-362C5467-0E1C-48B7-8117-E412A3580D59

Q34014581-4F7F83DB-D915-43F1-A191-8CA3399202CE

Q34014581-714FDEF6-A4E8-41A7-9FD8-589CB91D839D

P304

Q34014581-2015D4B9-6A6E-416D-9F00-449F9DDCB7DC

P31

Q34014581-AEB89A62-0D4B-4770-8AC8-71A62B3C9B03

P356

Q34014581-AA51BBC1-17F2-4D19-BF5A-6B38C63A26D3

P407

Q34014581-5E4B7AE6-288D-47F2-85FE-182BF3071EF5

P478

Q34014581-D39A5A93-B472-4B6E-B156-3D8149EDA50B

P50

Q34014581-277BA8B5-BF05-4E84-A7B6-73F519CACB2A

Q34014581-81509FED-C39C-4B2B-B6A1-465D9C2E22B6

P577

Q34014581-6D03CB0C-9E83-477B-85C9-EB1C2DCCB3D5

P5875

Q34014581-165D25DE-A243-48E8-A464-A6FD229CD2DB

P698

Q34014581-C645503B-56ED-4039-B1D0-7C14386DB30F

P932

Q34014581-33F6B271-EF7F-483D-86AB-4076E63D4D24

P356

P1433

BioMed Research International

P1476

Rho GTPase-activating protein ...... steosarcoma risk and prognosis

@en

P2093

Hua Xu

http://www.w3.org/2001/XMLSchema#string

Yang Wu

http://www.w3.org/2001/XMLSchema#string

Zhe Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Untranslated regions of mRNAs.

Children's Oncology Group's 2013 blueprint for research: bone tumors

Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion

Protein tyrosine phosphatase receptor type Z is involved in hippocampus-dependent memory formation through dephosphorylation at Y1105 on p190 RhoGAP

P190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer

Mitotic down-regulation of p190RhoGAP is required for the successful completion of cytokinesis

The Tumor Suppressor, p190RhoGAP, Differentially Initiates Apoptosis and Confers Docetaxel Sensitivity to Breast Cancer Cells.

p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3.

p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas.

RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity.

P304

396947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/396947

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264903013

http://www.w3.org/2001/XMLSchema#string

P698

25136583

http://www.w3.org/2001/XMLSchema#string

P932

4124850

http://www.w3.org/2001/XMLSchema#string